US Drug Recall Register
Class II · Moderate risk Terminated Initiated Jul 2, 2013 (13 years ago)

WARFARIN SODIUM Tablet

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Labeling: Label Mixup; WARFARIN SODIUM, Tablet, 0.5 mg (1/2 of 1 mg) may be potentially mislabeled as SODIUM CHLORIDE, Tablet, 1 mg, NDC 00223176001, Pedigree: AD70636_1, EXP: 5/29/2014.

What was recalled

WARFARIN SODIUM Tablet, 0.5 mg (1/2 of 1 mg), Rx only, Distributed by: AidaPak Service, LLC, NDC 51672402701

Recalling firm
Aidapak Services, LLC
Origin
WA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-602-2014

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Warfarin recalls

See all
Class II · Moderate risk Terminated

Warfarin Sodium Tablets

Reason Failed Impurities/Degradation Specifications

Rising Pharmaceuticals NDC 57237-119-01 D-0348-2023
Class II · Moderate risk Terminated

Warfarin Sodium Tablets

Reason CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.

Cardinal Healthcare D-0201-2024
Class II · Moderate risk Terminated

Warfarin Sodium Tablets

Reason CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.

Cardinal Healthcare D-0200-2024
Class II · Moderate risk Terminated

Warfarin 2.5 ng Lactose Free Caps

Reason Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.

Health Innovations Pharmacy, Inc D-1029-2015
Class III · Low risk Terminated

Warfarin Sodium Tablets

Reason Failed Content Uniformity Specifications.

Taro Pharmaceuticals U.S.A., Inc. D-1584-2014